Ticker Details
Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
IPO Date:	November 19, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$12.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.48 | 3.29%
Avg Daily Range (30 D):	$3.81 | 1.59%
Avg Daily Range (90 D):	$3.58 | 1.78%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.68M
Avg Daily Volume (90 D):	.59M

Trade Size
Avg Trade Size (Sh.):	73
Avg Trade Size (Sh.) (30 D):	41
Avg Trade Size (Sh.) (90 D):	41

Institutional Trades
Total Institutional Trades:	3,819
Avg Institutional Trade:	$4.27M
Avg Institutional Trade (30 D):	$31.04M
Avg Institutional Trade (90 D):	$18.24M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.51M
Avg Closing Trade (30 D):	$53.24M
Avg Closing Trade (90 D):	$29.93M
Avg Closing Volume:	58.77K

News

Jul 6, 2026 @ 10:10 PM These 3 Stocks Trounced the S&P 500 in the First H... Source: Adria Cimino

Jul 2, 2026 @ 12:05 PM Is Axsome Therapeutics Stock a Millionaire Maker? ... Source: Adria Cimino

Jun 26, 2026 @ 11:00 AM Axsome Therapeutics Initiates FOCUS-3 Phase 3 Tria... Source: Axsome Therapeutics

Jun 17, 2026 @ 1:18 AM Hypercharge Announces Issuance of Equity Grants Source: Hypercharge Networks Corp.

Jun 16, 2026 @ 7:30 AM 3 Under-the-Radar Stocks to Buy and Hold for a Dec... Source: Prosper Junior Bakiny

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.72	$-1.26	$-.55
Diluted EPS	$-3.72	$-1.26	$-.55
Revenue	$708.24M	$191.2M	$196M
Gross Profit
Net Income / Loss	$-188.3M	$-64.54M	$-28.56M
Operating Income / Loss	$-173.14M	$-63.36M	$-26.96M
Cost of Revenue
Net Cash Flow	$4.2M	$-17.83M	$-2.34M
PE Ratio